Sleep Extension for High Blood Pressure

Recruiting in Palo Alto (17 mi)

Overseen byMarwah Abdalla, MD, MPH

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Columbia University

No Placebo Group

Trial Summary

What is the purpose of this trial?The purpose of this study is to examine the impact that sleep duration has on blood pressure (BP) levels during sleep. The investigator will examine the effect of an 8-week sleep hygiene/extension intervention vs. control on sleep BP.

Eligibility Criteria

This trial is for English-speaking adults over 18 who sleep less than 7 hours a night. It's not suitable for those with arm circumference >50 cm, end-stage renal disease, high risk of sleep apnea or insomnia, depression, perimenopausal women with hot flashes, or if pregnant/planning to be within the study period.

Inclusion Criteria

You sleep less than 7 hours per night, as reported by yourself every day.

I am an adult who speaks English.

I am 18 years old or older.

Exclusion Criteria

You have a high risk of depression based on a questionnaire called the PHQ-8.

I have a high risk of insomnia or have used prescription sleep aids.

You have swelling in your arm or cannot wear a device for a certain amount of time.

+8 more

Participant Groups

The study compares an 8-week program designed to improve sleep habits and extend sleep time against usual care to see how it affects blood pressure during sleep.

2Treatment groups

Experimental Treatment

Active Control

Group I: Sleep Hygiene/Extension InterventionExperimental Treatment1 Intervention

Participants with short sleep duration will receive a 60-minute educational session on sleep hygiene/extension. Over an 8-week period, participants will receive weekly phone or Zoom video calls from the Educational Research Coordinator to review additional materials including handouts and/or complete questionnaires about sleep. Participants will undergo sleep tracking/monitoring during the 8-week period, and repeat BP/heart rate monitoring for 24 hours after the 8-week period.

Group II: Control ConditionActive Control1 Intervention

Participants with short sleep duration will receive a 60-minute educational session on sleep physiology. Over an 8-week period, participants will receive weekly phone or Zoom video calls from the Educational Research Coordinator to review additional materials including handouts. Participants will undergo sleep tracking/monitoring during the 8-week period, and repeat BP/heart rate monitoring for 24 hours after the 8-week period.